You are here
Treatment with a drug causing mydriasis or miosis
Angle-closure glaucoma - Treatment with a drug causing mydriasis or miosis Factor
Last reviewed for CCPS 18 July 2006.
Investigative Documents
Medical Report - Drug Treatment - Angle-Closure Glaucoma [MR9203] Preliminary questions [11946]
11960 the condition under consideration is acute angle-closure glaucoma. the veteran underwent treatment with a drug that can cause mydriasis or miosis within the 24 hours before the clinical onset of the condition under consideration. 11962 — the veteran has established the causal connection between the treatment with a drug causing mydriasis or miosis and VEA service for the clinical onset of the condition under consideration. 11965 — the veteran has established the causal connection between the treatment with a drug causing mydriasis or miosis and operational service for the clinical onset of the condition under consideration. or 11966 — the veteran has established the causal connection between the treatment with a drug causing mydriasis or miosis and eligible service for the clinical onset of the condition under consideration. Clinical onset and operational service [11965] or 11972 — the identified illness or injury, for which the treatment with a drug that can cause mydriasis or miosis was undergone, is causally related to operational service. Clinical onset and eligible service [11966]
11973 — the identified illness or injury, for which the treatment with a drug that can cause mydriasis or miosis was undergone, is causally related to eligible service.